- Blood Pressure and Diabetic Nephropathy
- Long-Term Effect of an Education Program (HyPOS) on the Incidence of Severe Hypoglycemia in Patients With Type 1 Diabetes
- Subclinical Hypothyroidism Is Associated With Reduced All-Cause Mortality in Patients With Type 2 Diabetes
- Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
- Immunologic Tolerance to the Insulin Analogue Glulisine
December 17th, 2009 | 
Author: 
Posted in - The American Diabetes Association Encourages Community Organizations To Join The Movement To Stop DiabetesThe American Diabetes Association announced today their efforts to further engage community organizations across the country in raising awareness about the seriousness of diabetes and its complications through the Association's Stop Diabetes movement...
- Agency For Healthcare Research And Quality News And Numbers: High Cholesterol, Diabetes Lead Drug Spending For The ElderlyPurchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 - about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers...
- Glycated Hemoglobin Tests See Increasing UseGlycated hemoglobin (HbA1c) testing is one of the success stories of point-of-care diagnostics, and an area that will experience higher growth rates than other POC tests as a result of expert recommendations, new cases and booming mail-in test sales, according to the new report "Point-of-care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads, […]
- Diamyd Medical: Diamyd US Phase III Study Well Under WayDiamyd Medical (STO:DIAMB)(Pink Sheets:DMYDY) announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company's lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA...